Mangoceuticals, Inc. Common Stock

MGRX

Mangoceuticals, Inc. (MGRX) is a biopharmaceutical company focused on the development and commercialization of innovative nutraceutical and pharmaceutical products. The company leverages its expertise in formulation science to create health and wellness products that address various medical and nutritional needs. Mangoceuticals aims to integrate natural ingredients with advanced biomedical research to bring effective solutions to consumers.

$0.41 +0.01 (1.73%)
🚫 Mangoceuticals, Inc. Common Stock does not pay dividends

Company News

Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc.
GlobeNewswire Inc. • Mangoceuticals, Inc. • March 17, 2026

Mangoceuticals filed a civil lawsuit against former technology consulting firm Clarity Ventures seeking over $73 million in damages for failure to deliver a fully functional, HIPAA-compliant ERP and eCommerce platform. Clarity has denied allegations and asserted counterclaims for unpaid invoices, which Mangoceuticals disputes. The company has sin...

Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds
GlobeNewswire Inc. • Na • March 6, 2026

Mangoceuticals, Inc. filed a PCT international patent application on February 26, 2026, to secure global patent protection for MGX-0024, an antiviral animal feed and drinking water additive. The filing follows recent clinical trial results showing zero respiratory-related mortality in 29,000 birds and prophylactic benefits against H5N1. The techn...

Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs
GlobeNewswire Inc. • Mangoceuticals Investor Relations • November 14, 2025

Mangoceuticals launches weight-management programs MangoRx Direct and PeachesRx Direct, enabling patients to access FDA-approved GLP-1 medications like Zepbound and Wegovy through telehealth consultations at $99 per month.

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division
GlobeNewswire Inc. • N/A • April 25, 2025

Mangoceuticals, a health and wellness company, has acquired the intellectual property and assets of Smokeless Technology Corp., a Canadian-based pouch innovation company. This acquisition will allow Mangoceuticals to expand into the growing oral pouch delivery market. The company has also appointed Tim Corkum, a former executive at Philip Morris,...

Azz Inc. COO acquires $21.2k in company stock By Investing.com - Investing.com Australia
Investing.com • Brando Bricchi • July 12, 2024

Mangoceuticals, a health and wellness company, has appointed Dr. Douglas Christianson as the new Director of Medical Research and Product Innovation. Dr. Christianson will lead the company's product development efforts, particularly in areas like erectile dysfunction, hair growth, weight loss, and hormone replacement therapies.

Related Companies